Hervote 0.03/3 MG Tablet 21

Hervote 0.03/3 MG Tablet 21 may interact with the following medicines:

• Anticoagulants (e.g., warfarin, rivaroxaban): The concomitant use may increase blood clotting risk.
• Anti-seizure medications (e.g., phenytoin, carbamazepine): The concomitant use may reduce effectiveness of this tablet.
• Antibiotics (e.g., amoxicillin, doxycycline): The concomitant use may lower hormone levels and contraceptive effect of this tablet.
   

Hervote 0.03/3 MG Tablet 21 may interact with the following foods:

• Grapefruit juice: Grapefruit juice may interfere with hormone metabolism and should be avoided.

Hervote 0.03/3 MG Tablet 21 may interact with the following conditions:

• History of blood clots or deep vein thrombosis (DVT): This tablet may increase the risk of clot formation, worsening pre-existing conditions.
• Stroke or heart attack: This medication can elevate cardiovascular risks in individuals with a prior history of such events.
• Uncontrolled high blood pressure: It may raise blood pressure further, heightening the risk of cardiovascular complications.
• Migraine with aura: Use may increase the chance of vascular events in patients with this type of migraine.
• Breast cancer or hormone-sensitive cancers: This tablet could potentially influence hormone levels, which may aggravate hormone-driven cancers.

Take the daily dose of Hervote 0.03/3 MG Tablet 21 as your doctor prescribes. The exact dosage is determined by your doctor based on your condition, severity of symptoms, and response to treatment.

Overdose of Hervote 0.03/3 MG Tablet 21 may cause nausea, vomiting, and vaginal bleeding. In case of overdose, seek medical attention immediately.

If you miss a dose of Hervote 0.03/3 MG Tablet 21, take it as soon as you remember. If you miss two or more active tablets, refer to the pack insert or your doctor for instructions, as you may need to use additional contraception for a few days.